Obesity, ectopic fat and cardiac metabolism

References

• Karpe F, Pinnick KE. Biology of upper-body and lower-body adipose tissue–link to whole-body phenotypes. Nat Rev Endocrinol. 2015;11(2):90–100.
   PubMed Web of Science ®Google Scholar
• Thomas EL, Saeed N, Hajnal JV, et al. Magnetic resonance imaging of total body fat. J Appl Physiol (1985). 1998;85(5):1778–1785.
   PubMed Web of Science ®Google Scholar
• Kvist H, Ströström L, Tylen U. Adipose tissue volume determinations in women by computed tomography: technical considerations. Int J Obes. 1986;10(1):53–67.
   PubMed Web of Science ®Google Scholar
• Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham heart study. Circulation. 2007;116(1):39–48.
   PubMed Web of Science ®Google Scholar
• Liu J, Fox CS, Hickson DA, et al. Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson heart study. J Clin Endocrinol Metab. 2010;95(12):5419–5426.
   PubMed Web of Science ®Google Scholar
• Preis SR, Massaro JM, Robins SJ, et al. Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the framingham heart study. Obesity (Silver Spring). 2010;18(11):2191–2198.
   PubMed Web of Science ®Google Scholar
• Abraham TM, Pedley A, Massaro JM, et al. Association between visceral and subcutaneous adipose depots and incident cardiovascular disease risk factors. Circulation. 2015;132(17):1639–1647.
   PubMed Web of Science ®Google Scholar
• Després JP, Lemieux I, Bergeron J, et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol. 2008;28(6):1039–1049.
   PubMed Web of Science ®Google Scholar
• Heilbronn LK, Rood J, Janderova L, et al. Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. J Clin Endocrinol Metab. 2004;89(4):1844–1848.
   PubMed Web of Science ®Google Scholar
• Virtue S, Vidal-Puig A. It’s not how fat you are, it’s what you do with it that counts. PLoS Biol. 2008;6(9):e237.
   PubMed Web of Science ®Google Scholar
• Neeland IJ, Poirier P, Despres JP. Cardiovascular and metabolic heterogeneity of obesity: clinical challenges and implications for management. Circulation. 2018;137(13):1391–1406.
   PubMed Web of Science ®Google Scholar
• Després JP. Body fat distribution and risk of cardiovascular disease: an update. Circulation. 2012;126(10):1301–1313.
   PubMed Web of Science ®Google Scholar
• Arsenault BJ, Beaumont EP, Despres JP, et al. Mapping body fat distribution: a key step towards the identification of the vulnerable patient? Ann Med. 2012;44(8):758–772.
   PubMed Web of Science ®Google Scholar
• Iozzo P. Myocardial, perivascular, and epicardial fat. Diabetes Care. 2011;34(Suppl 2):S371–379.
   PubMed Web of Science ®Google Scholar
• Iacobellis G. Epicardial and pericardial fat: close, but very different. Obesity (Silver Spring). 2009;17(4): 625. author reply 626-627.
   PubMed Web of Science ®Google Scholar
• Szczepaniak LS, Dobbins RL, Metzger GJ, et al. Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging. Magn Reson Med. 2003;49(3):417–423.
   PubMed Web of Science ®Google Scholar
• Iacobellis G, Corradi D, Sharma AM. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med. 2005;2(10):536–543.
   PubMedGoogle Scholar
• Iacobellis G. Local and systemic effects of the multifaceted epicardial adipose tissue depot. Nat Rev Endocrinol. 2015;11(6):363–371.
   PubMed Web of Science ®Google Scholar
• Lavie CJ, Pandey A, Lau DH, et al. Obesity and atrial fibrillation prevalence, pathogenesis, and prognosis: effects of weight loss and exercise. J Am Coll Cardiol. 2017;70(16):2022–2035.
   PubMed Web of Science ®Google Scholar
• Sacks HS, Fain JN. Human epicardial adipose tissue: a review. Am Heart J. 2007;153(6):907–917.
   PubMed Web of Science ®Google Scholar
• Fain JN, Sacks HS, Buehrer B, et al. Identification of omentin mRNA in human epicardial adipose tissue: comparison to omentin in subcutaneous, internal mammary artery periadventitial and visceral abdominal depots. Int J Obes (Lond). 2008;32(5):810–815.
   PubMed Web of Science ®Google Scholar
• Sacks HS, Fain JN, Bahouth SW, et al. Adult epicardial fat exhibits beige features. J Clin Endocrinol Metab. 2013;98(9):E1448–1455.
   PubMed Web of Science ®Google Scholar
• Chechi K, Blanchard PG, Mathieu P, et al. Brown fat like gene expression in the epicardial fat depot correlates with circulating HDL-cholesterol and triglycerides in patients with coronary artery disease. Int J Cardiol. 2013;167(5):2264–2270.
   PubMed Web of Science ®Google Scholar
• Vijgen GH, Bouvy ND, Teule GJ, et al. Increase in brown adipose tissue activity after weight loss in morbidly obese subjects. J Clin Endocrinol Metab. 2012;97(7):E1229–1233.
   PubMed Web of Science ®Google Scholar
• Guglielmi V, Sbraccia P. Epicardial adipose tissue: at the heart of the obesity complications. Acta Diabetol. 2017;54(9):805–812.
   PubMed Web of Science ®Google Scholar
• Gaborit B, Sengenes C, Ancel P, et al. Role of epicardial adipose tissue in health and disease: a matter of fat? Compr Physiol. 2017;7(3):1051–1082.
   PubMed Web of Science ®Google Scholar
• Marchington JM, Pond CM. Site-specific properties of pericardial and epicardial adipose tissue: the effects of insulin and high-fat feeding on lipogenesis and the incorporation of fatty acids in vitro. Int J Obes. 1990;14(12):1013–1022.
   PubMed Web of Science ®Google Scholar
• Packer M. Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium. J Am Coll Cardiol. 2018;71(20):2360–2372.
   PubMed Web of Science ®Google Scholar
• Alexopoulos N, McLean DS, Janik M, et al. Epicardial adipose tissue and coronary artery plaque characteristics. Atherosclerosis. 2010;210(1):150–154.
   PubMed Web of Science ®Google Scholar
• Iacobellis G, Ribaudo MC, Assael F, et al. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab. 2003;88(11):5163–5168.
   PubMed Web of Science ®Google Scholar
• McGavock JM, Victor RG, Unger RH, et al. American college of p, the american physiological s. adiposity of the heart, revisited. Ann Intern Med. 2006;144(7):517–524.
   PubMed Web of Science ®Google Scholar
• Szczepaniak LS, Victor RG, Orci L, et al. Forgotten but not gone: the rediscovery of fatty heart, the most common unrecognized disease in America. Circ Res. 2007;101(8):759–767.
   PubMed Web of Science ®Google Scholar
• Kankaanpaa M, Lehto HR, Parkka JP, et al. Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. J Clin Endocrinol Metab. 2006;91(11):4689–4695.
   PubMed Web of Science ®Google Scholar
• Banerjee R, Rial B, Holloway CJ, et al. Evidence of a direct effect of myocardial steatosis on lv hypertrophy and diastolic dysfunction in adult and adolescent obesity. JACC Cardiovasc Imaging. 2015;8(12):1468–1470.
   PubMed Web of Science ®Google Scholar
• Rayner JJ, Banerjee R, Holloway CJ, et al. The relative contribution of metabolic and structural abnormalities to diastolic dysfunction in obesity. Int J Obes (Lond). 2018;42(3):441–447.
   PubMed Web of Science ®Google Scholar
• Viljanen AP, Karmi A, Borra R, et al. Effect of caloric restriction on myocardial fatty acid uptake, left ventricular mass, and cardiac work in obese adults. Am J Cardiol. 2009;103(12):1721–1726.
   PubMed Web of Science ®Google Scholar
• Nyman K, Graner M, Pentikainen MO, et al. Cardiac steatosis and left ventricular function in men with metabolic syndrome. J Cardiovasc Magn Reson. 2013;15:103.
   PubMed Web of Science ®Google Scholar
• McGavock JM, Lingvay I, Zib I, et al. Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation. 2007;116(10):1170–1175.
   PubMed Web of Science ®Google Scholar
• Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2014;384(9945):766–781.
   PubMed Web of Science ®Google Scholar
• Cheng KH, Chu CS, Lee KT, et al. Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease. Int J Obes (Lond). 2008;32(2):268–274.
   PubMed Web of Science ®Google Scholar
• Company JM, Booth FW, Laughlin MH, et al. Epicardial fat gene expression after aerobic exercise training in pigs with coronary atherosclerosis: relationship to visceral and subcutaneous fat. J Appl Physiol (1985). 2010;109(6):1904–1912.
   PubMed Web of Science ®Google Scholar
• Clement K, Basdevant A, Dutour A. Weight of pericardial fat on coronaropathy. Arterioscler Thromb Vasc Biol. 2009;29(5):615–616.
   PubMed Web of Science ®Google Scholar
• Rosito GA, Massaro JM, Hoffmann U, et al. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham heart study. Circulation. 2008;117(5):605–613.
   PubMed Web of Science ®Google Scholar
• Mazurek T, Zhang L, Zalewski A, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation. 2003;108(20):2460–2466.
   PubMed Web of Science ®Google Scholar
• Vela D, Buja LM, Madjid M, et al. The role of periadventitial fat in atherosclerosis. Arch Pathol Lab Med. 2007;131(3):481–487.
   PubMed Web of Science ®Google Scholar
• Yudkin JS, Eringa E, Stehouwer CD. “Vasocrine” signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet. 2005;365(9473):1817–1820.
   PubMed Web of Science ®Google Scholar
• Baker AR, Silva NF, Quinn DW, et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol. 2006;5:1.
   PubMed Web of Science ®Google Scholar
• Ishii T, Asuwa N, Masuda S, et al. The effects of a myocardial bridge on coronary atherosclerosis and ischaemia. J Pathol. 1998;185(1):4–9.
   PubMed Web of Science ®Google Scholar
• Ishikawa Y, Ishii T, Asuwa N, et al. Absence of atherosclerosis evolution in the coronary arterial segment covered by myocardial tissue in cholesterol-fed rabbits. Virchows Arch. 1997;430(2):163–171.
   PubMed Web of Science ®Google Scholar
• Angelini P, Velasco JA, Ott D, et al. Anomalous coronary artery arising from the opposite sinus: descriptive features and pathophysiologic mechanisms, as documented by intravascular ultrasonography. J Invasive Cardiol. 2003;15(9):507–514.
   PubMedGoogle Scholar
• Krahn AD, Manfreda J, Tate RB, et al. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba follow-up study. Am J Med. 1995;98(5):476–484.
   PubMed Web of Science ®Google Scholar
• Venteclef N, Guglielmi V, Balse E, et al. Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines. Eur Heart J. 2015;36(13):795–805a.
   PubMed Web of Science ®Google Scholar
• Ashrafian H, Frenneaux MP, Opie LH. Metabolic mechanisms in heart failure. Circulation. 2007;116(4):434–448.
   PubMed Web of Science ®Google Scholar
• Opie LH. Substrate utilization and glycolysis in the heart. Cardiology. 1971;56(1):2–21.
   PubMed Web of Science ®Google Scholar
• Opie LH. Cardiac metabolism–emergence, decline, and resurgence. Part I Cardiovasc Res. 1992;26(8):721–733.
   PubMed Web of Science ®Google Scholar
• Randle PJ, Garland PB, Hales CN, et al. The glucose fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963;1:785–789.
   PubMed Web of Science ®Google Scholar
• Lopaschuk GD, Ussher JR, Folmes CD, et al. Myocardial fatty acid metabolism in health and disease. Physiol Rev. 2010;90(1):207–258.
   PubMed Web of Science ®Google Scholar
• Rider OJ, Francis JM, Tyler D, et al. Effects of weight loss on myocardial energetics and diastolic function in obesity. Int J Cardiovasc Imaging. 2013;29(5):1043–1050.
   PubMed Web of Science ®Google Scholar
• D’Souza K, Nzirorera C, Kienesberger PC. Lipid metabolism and signaling in cardiac lipotoxicity. Biochim Biophys Acta. 2016;1861(10):1513–1524.
   PubMed Web of Science ®Google Scholar
• Fukushima A, Lopaschuk GD. Cardiac fatty acid oxidation in heart failure associated with obesity and diabetes. Biochim Biophys Acta. 2016;1861(10):1525–1534.
   PubMed Web of Science ®Google Scholar
• Taegtmeyer H, Young ME, Lopaschuk GD, et al. Assessing cardiac metabolism: a scientific statement from the American Heart Association. Circ Res. 2016;118(10):1659–1701.
   PubMed Web of Science ®Google Scholar
• Goldberg IJ, Trent CM, Schulze PC. Lipid metabolism and toxicity in the heart. Cell Metab. 2012;15(6):805–812.
   PubMed Web of Science ®Google Scholar
• Zlobine I, Gopal K, Ussher JR. Lipotoxicity in obesity and diabetes-related cardiac dysfunction. Biochim Biophys Acta. 2016;1861(10):1555–1568.
   PubMed Web of Science ®Google Scholar
• Park TS, Goldberg IJ. Sphingolipids, lipotoxic cardiomyopathy, and cardiac failure. Heart Fail Clin. 2012;8(4):633–641.
   PubMed Web of Science ®Google Scholar
• Wende AR, Abel ED. Lipotoxicity in the heart. Biochim Biophys Acta. 2010;1801(3):311–319.
   PubMed Web of Science ®Google Scholar
• Unger RH. Lipotoxic diseases. Annu Rev Med. 2002;53:319–336.
   PubMed Web of Science ®Google Scholar
• Gray S, Kim JK. New insights into insulin resistance in the diabetic heart. Trends Endocrinol Metab. 2011;22(10):394–403.
   PubMed Web of Science ®Google Scholar
• Lingvay I, Esser V, Legendre JL, et al. Noninvasive quantification of pancreatic fat in humans. J Clin Endocrinol Metab. 2009;94(10):4070–4076.
   PubMed Web of Science ®Google Scholar
• Lopaschuk GD, Folmes CD, Stanley WC. Cardiac energy metabolism in obesity. Circ Res. 2007;101(4):335–347.
   PubMed Web of Science ®Google Scholar
• Davila-Roman VG, Vedala G, Herrero P, et al. Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 2002;40(2):271–277.
   PubMed Web of Science ®Google Scholar
• Levelt E, Rodgers CT, Clarke WT, et al. Cardiac energetics, oxygenation, and perfusion during increased workload in patients with type 2 diabetes mellitus. Eur Heart J. 2016;37(46):3461–3469.
   PubMed Web of Science ®Google Scholar
• Britton KA, Fox CS. Ectopic fat depots and cardiovascular disease. Circulation. 2011;124(24):e837–841.
   PubMed Web of Science ®Google Scholar
• Iozzo P. Metabolic toxicity of the heart: insights from molecular imaging. Nutr Metab Cardiovasc Dis. 2010;20(3):147–156.
   PubMed Web of Science ®Google Scholar
• Peterson LR, Herrero P, Schechtman KB, et al. Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation. 2004;109(18):2191–2196.
   PubMed Web of Science ®Google Scholar
• Herrero P, Peterson LR, McGill JB, et al. Increased myocardial fatty acid metabolism in patients with type 1 diabetes mellitus. J Am Coll Cardiol. 2006;47(3):598–604.
   PubMed Web of Science ®Google Scholar
• Duncan JG, Bharadwaj KG, Fong JL, et al. Rescue of cardiomyopathy in peroxisome proliferator-activated receptor-alpha transgenic mice by deletion of lipoprotein lipase identifies sources of cardiac lipids and peroxisome proliferator-activated receptor-alpha activators. Circulation. 2010;121(3):426–435.
   PubMed Web of Science ®Google Scholar
• Taegtmeyer H, Golfman L, Sharma S, et al. Linking gene expression to function: metabolic flexibility in the normal and diseased heart. Ann N Y Acad Sci. 2004;1015:202–213.
   PubMed Web of Science ®Google Scholar
• Bucci M, Borra R, Nagren K, et al. Trimetazidine reduces endogenous free fatty acid oxidation and improves myocardial efficiency in obese humans. Cardiovasc Ther. 2012;30(6):333–341.
   PubMed Web of Science ®Google Scholar
• Rider OJ, Cox P, Tyler D, et al. Myocardial substrate metabolism in obesity. Int J Obes (Lond). 2013;37(7):972–979.
   PubMed Web of Science ®Google Scholar
• Neubauer S. The failing heart–an engine out of fuel. N Engl J Med. 2007;356(11):1140–1151.
   PubMed Web of Science ®Google Scholar
• Neubauer S, Horn M, Cramer M, et al. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation. 1997;96(7):2190–2196.
   PubMed Web of Science ®Google Scholar
• Perseghin G, Lattuada G, De Cobelli F, et al. Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver. Hepatology. 2008;47(1):51–58.
   PubMed Web of Science ®Google Scholar
• Rider OJ, Francis JM, Ali MK, et al. Effects of catecholamine stress on diastolic function and myocardial energetics in obesity. Circulation. 2012;125(12):1511–1519.
   PubMed Web of Science ®Google Scholar
• Levelt E, Pavlides M, Banerjee R, et al. Ectopic and visceral fat deposition in lean and obese patients with type 2 diabetes. J Am Coll Cardiol. 2016;68(1):53–63.
   PubMed Web of Science ®Google Scholar
• Lin CH, Kurup S, Herrero P, et al. Myocardial oxygen consumption change predicts left ventricular relaxation improvement in obese humans after weight loss. Obesity (Silver Spring). 2011;19(9):1804–1812.
   PubMed Web of Science ®Google Scholar
• Utz W, Engeli S, Haufe S, et al. Moderate dietary weight loss reduces myocardial steatosis in obese and overweight women. Int J Cardiol. 2013;167(3):905–909.
   PubMed Web of Science ®Google Scholar
• Schrauwen-Hinderling VB, Hesselink MK, Meex R, et al. Improved ejection fraction after exercise training in obesity is accompanied by reduced cardiac lipid content. J Clin Endocrinol Metab. 2010;95(4):1932–1938.
   PubMed Web of Science ®Google Scholar
• Schrauwen-Hinderling VB, Meex RC, Hesselink MK, et al. Cardiac lipid content is unresponsive to a physical activity training intervention in type 2 diabetic patients, despite improved ejection fraction. Cardiovasc Diabetol. 2011;10:47.
   PubMed Web of Science ®Google Scholar
• Hammer S, Snel M, Lamb HJ, et al. Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases myocardial triglyceride content and improves myocardial function. J Am Coll Cardiol. 2008;52(12):1006–1012.
   PubMed Web of Science ®Google Scholar
• Lautamaki R, Airaksinen KE, Seppanen M, et al. Rosiglitazone improves myocardial glucose uptake in patients with type 2 diabetes and coronary artery disease: a 16-week randomized, double-blind, placebo-controlled study. Diabetes. 2005;54(9):2787–2794.
   PubMed Web of Science ®Google Scholar
• Zib I, Jacob AN, Lingvay I, et al. Effect of pioglitazone therapy on myocardial and hepatic steatosis in insulin-treated patients with type 2 diabetes. J Investig Med. 2007;55(5):230–236.
   PubMed Web of Science ®Google Scholar
• Hallsten K, Virtanen KA, Lonnqvist F, et al. Enhancement of insulin-stimulated myocardial glucose uptake in patients with Type 2 diabetes treated with rosiglitazone. Diabet Med. 2004;21(12):1280–1287.
   PubMed Web of Science ®Google Scholar
• van der Meer RW, Rijzewijk LJ, de Jong HW, et al. Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitus. Circulation. 2009;119(15):2069–2077.
   PubMed Web of Science ®Google Scholar
• Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753–761.
   PubMed Web of Science ®Google Scholar
• Adams TD, Mehta TS, Davidson LE, et al. All-cause and cause-specific mortality associated with bariatric surgery: a review. Curr Atheroscler Rep. 2015;17(12):74.
   PubMed Web of Science ®Google Scholar
• Gaborit B, Jacquier A, Kober F, et al. Effects of bariatric surgery on cardiac ectopic fat: lesser decrease in epicardial fat compared to visceral fat loss and no change in myocardial triglyceride content. J Am Coll Cardiol. 2012;60(15):1381–1389.
   PubMed Web of Science ®Google Scholar
• Abdesselam I, Dutour A, Kober F, et al. Time course of change in ectopic fat stores after bariatric surgery. J Am Coll Cardiol. 2016;67(1):117–119.
   PubMed Web of Science ®Google Scholar